Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of Weekly Oxaliplatin and Capecitabine (XELOX) in Combination With Preoperative Radiotherapy in Patients With MRI Defined Locally Advanced Rectal Cancer

NCT00174616 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00174616
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00174616 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of Weekly Oxaliplatin and Capecitabine (XELOX) in Combination With Preoperative Radiotherapy in Patients With MRI Defined Locally Advanced Rectal Cancer
Lead sponsor
Sanofi
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2003
Completion date
November 30, 2007
Enrollment
87 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

rectal neoplasms